T1	HMM 581 606	efficacy and tolerability
T2	HMM 1249 1263	Adverse events
T3	HMM 1613 1634	lost HCV RNA in serum
T4	HMM 1679 1695	HCV RNA negative
T5	HMM 1729 1753	Sustained response rates
T6	HMM 1897 1920	moderate adverse events
T7	HMM 2047 2090	anaemia, neutropenia, nausea and depression
T8	HMM 2271 2296	sustained response rates.
